147 related articles for article (PubMed ID: 1663302)
21. Efficacy of viral components of a nonabortigenic combination vaccine for prevention of respiratory and reproductive system diseases in cattle.
Talens LT; Beckenhauer WH; Thurber ET; Cooley AJ; Schultz RD
J Am Vet Med Assoc; 1989 May; 194(9):1273-80. PubMed ID: 2542202
[TBL] [Abstract][Full Text] [Related]
22. A new inactivated BVDV genotype I and II vaccine. An immunisation and challenge study with BVDV genotype I.
Beer M; Hehnen HR; Wolfmeyer A; Poll G; Kaaden OR; Wolf G
Vet Microbiol; 2000 Nov; 77(1-2):195-208. PubMed ID: 11042413
[TBL] [Abstract][Full Text] [Related]
23. Virological and pathological findings in sheep fetuses following experimental infection of pregnant ewes with cytopathogenic-bovine-virus diarrhoea virus.
Hewicker-Trautwein M; Liess B; Frey HR; Trautwein G
Zentralbl Veterinarmed B; 1994 Jun; 41(4):264-76. PubMed ID: 7839747
[TBL] [Abstract][Full Text] [Related]
24. Virus neutralizing antibodies against a panel of 18 BVDV isolates in calves vaccinated with Rispoval RS-BVD.
Hamers C; di Valentin E; Lecomte C; Lambot M; Joris E; Genicot B; Pastoret PP
J Vet Med B Infect Dis Vet Public Health; 2000 Dec; 47(10):721-6. PubMed ID: 11204126
[TBL] [Abstract][Full Text] [Related]
25. Antigenically different pestivirus strains induce congenital infection in sheep: a model for bovine virus diarrhea virus vaccine efficacy studies.
Bruschke CJ; van Rijn PA; Moormann RJ; van Oirschot JT
Vet Microbiol; 1996 May; 50(1-2):33-43. PubMed ID: 8810006
[TBL] [Abstract][Full Text] [Related]
26. Protective effects against abortion and fetal infection following exposure to bovine viral diarrhea virus and bovine herpesvirus 1 during pregnancy in beef heifers that received two doses of a multivalent modified-live virus vaccine prior to breeding.
Givens MD; Marley MS; Jones CA; Ensley DT; Galik PK; Zhang Y; Riddell KP; Joiner KS; Brodersen BW; Rodning SP
J Am Vet Med Assoc; 2012 Aug; 241(4):484-95. PubMed ID: 22852575
[TBL] [Abstract][Full Text] [Related]
27. Protection from persistent infection with a bovine viral diarrhea virus (BVDV) type 1b strain by a modified-live vaccine containing BVDV types 1a and 2, infectious bovine rhinotracheitis virus, parainfluenza 3 virus and bovine respiratory syncytial virus.
Xue W; Mattick D; Smith L
Vaccine; 2011 Jun; 29(29-30):4657-62. PubMed ID: 21596076
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of the induction of NS3 specific BVDV antibodies using a commercial inactivated BVDV vaccine in immunization and challenge trials.
Makoschey B; Sonnemans D; Bielsa JM; Franken P; Mars M; Santos L; Alvarez M
Vaccine; 2007 Aug; 25(32):6140-5. PubMed ID: 17336433
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of the vaccine potential of an equine herpesvirus type 1 vector expressing bovine viral diarrhea virus structural proteins.
Rosas CT; König P; Beer M; Dubovi EJ; Tischer BK; Osterrieder N
J Gen Virol; 2007 Mar; 88(Pt 3):748-757. PubMed ID: 17325347
[TBL] [Abstract][Full Text] [Related]
30. Duration of immunity of a quadrivalent vaccine against respiratory diseases caused by BHV-1, PI3V, BVDV, and BRSV in experimentally infected calves.
Peters AR; Thevasagayam SJ; Wiseman A; Salt JS
Prev Vet Med; 2004 Dec; 66(1-4):63-77. PubMed ID: 15579335
[TBL] [Abstract][Full Text] [Related]
31. Prevention of transplacental infection of bovine foetus by bovine viral diarrhoea virus through vaccination.
Patel JR; Shilleto RW; Williams J; Alexander DC
Arch Virol; 2002 Dec; 147(12):2453-63. PubMed ID: 12491111
[TBL] [Abstract][Full Text] [Related]
32. Foetal cross-protection experiments between type 1 and type 2 bovine viral diarrhoea virus in pregnant ewes.
Paton DJ; Sharp G; Ibata G
Vet Microbiol; 1999 Jan; 64(2-3):185-96. PubMed ID: 10028172
[TBL] [Abstract][Full Text] [Related]
33. Prevention of persistent infection in calves by vaccination of dams with noncytopathic type-1 modified-live bovine viral diarrhea virus prior to breeding.
Dean HJ; Hunsaker BD; Bailey OD; Wasmoen T
Am J Vet Res; 2003 May; 64(5):530-7. PubMed ID: 12755290
[TBL] [Abstract][Full Text] [Related]
34. Diagnosis of natural exposure to bovine viral diarrhea in a vaccinated herd by measuring extended antibody titers against bovine viral diarrhea virus.
Ross J
Can Vet J; 2003 Jan; 44(1):59-61. PubMed ID: 12619558
[TBL] [Abstract][Full Text] [Related]
35. Experimental fetal challenge using type II bovine viral diarrhea virus in cattle vaccinated with modified-live virus vaccine.
Brock KV; Cortese VS
Vet Ther; 2001; 2(4):354-60. PubMed ID: 19746658
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of a modified live virus type-1a bovine viral diarrhea virus vaccine (Singer strain) against a type-2 (strain 890) challenge.
Fairbanks K; Schnackel J; Chase CC
Vet Ther; 2003; 4(1):24-34. PubMed ID: 12756633
[TBL] [Abstract][Full Text] [Related]
37. Fetal protection following exposure to calves persistently infected with bovine viral diarrhea virus type 2 sixteen months after primary vaccination of the dams.
Ellsworth MA; Fairbanks KK; Behan S; Jackson JA; Goodyear M; Oien NL; Meinert TR; Leyh RD
Vet Ther; 2006; 7(3):295-304. PubMed ID: 17039452
[TBL] [Abstract][Full Text] [Related]
38. Safety and efficacy of an E2 glycoprotein subunit vaccine produced in mammalian cells to prevent experimental infection with bovine viral diarrhoea virus in cattle.
Pecora A; Aguirreburualde MS; Aguirreburualde A; Leunda MR; Odeon A; Chiavenna S; Bochoeyer D; Spitteler M; Filippi JL; Dus Santos MJ; Levy SM; Wigdorovitz A
Vet Res Commun; 2012 Sep; 36(3):157-64. PubMed ID: 22639081
[TBL] [Abstract][Full Text] [Related]
39. One year duration of immunity of the modified live bovine viral diarrhea virus type 1 and type 2 and bovine herpesvirus-1 fractions of Vista® Once SQ vaccine.
Purtle L; Mattick D; Schneider C; Smith L; Xue W; Trigo E
Vaccine; 2016 Mar; 34(13):1582-1588. PubMed ID: 26859238
[TBL] [Abstract][Full Text] [Related]
40. DNA vaccination against bovine viral diarrhoea virus induces humoral and cellular responses in cattle with evidence for protection against viral challenge.
Nobiron I; Thompson I; Brownlie J; Collins ME
Vaccine; 2003 May; 21(17-18):2082-92. PubMed ID: 12706698
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
